Viatris Inc. vs Abbvie Inc.
VTRS vs ABBV — side-by-side comparison from reported financials. VTRS leads 4, ABBV leads 8 of 12 comparable metrics.
Viatris Inc.
VTRS · Healthcare
$17.64+1.15%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | VTRS | ABBV |
|---|---|---|
| Price | $17.64 | $276.43 |
| Market cap | $20.3B | $488B |
| Revenue (TTM) | $14.7B | $64.4B |
| Revenue growth | -4.2% | +1.8% |
| Net margin | -2.8% | 9.8% |
| Free cash flow | $1.95B | $18.2B |
| Net cash (debt) | ($11.2B) | ($56.2B) |
| 1-year price return | +76.6% | +19.8% |
| P/E | 5.5 | 77.4 |
| P/E vs own history (cheap-side %) | 9% | 23% |
| Dividend yield | 2.75% | 2.45% |
| Return on equity | -3% | 96% |
| Altman Z-score | 0.99 | 2.33 |
| CV checks passed | 6 of 11 | 9 of 11 |
| Employees | 30,000 | 57,000 |
Full résumé-style profiles: VTRS CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.